Greg Veltri

Greg Veltri is a seasoned technical specialist with extensive experience in cytometry and biological sciences. Currently employed at De Novo Software since February 2022, Veltri previously served as the Scientific Director of Translational Immunology at KCAS Bioanalytical & Biomarker Services. A notable tenure at Sony Biotechnology Inc. involved roles such as Director of Biological Sciences and Business Development, alongside positions in global marketing management and technical sales. Early career experience includes pivotal roles in flow cytometry at National Jewish Health and Cancer Research UK, where core facilities were developed and managed. Veltri's academic credentials include a PhD in Chemistry with a concentration in Immunology from Ashley University and a BSc in Biochemistry from San Francisco State University. Additionally, Veltri's background encompasses research and medical roles in the United States Air Force and entrepreneurial efforts as President of Precision Engineering Incorporated.